Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.

@article{BoleasAguirre2008LongitudinalRW,
  title={Longitudinal results with intratympanic dexamethasone in the treatment of M{\'e}ni{\`e}re's disease.},
  author={Mar{\'i}a Soledad Boleas-Aguirre and F. R. Lin and Charles C Della Santina and Lloyd B. Minor and John P. Carey},
  journal={Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology},
  year={2008},
  volume={29 1},
  pages={33-8}
}
OBJECTIVE To assess patient satisfaction with vertigo control using intratympanic (IT) dexamethasone (12 mg/mL) for medically refractory unilateral Ménière's disease. STUDY DESIGN Retrospective study. SETTING Tertiary referral neurotology clinic. PATIENTS One hundred twenty-nine subjects diagnosed with unilateral Ménière's disease still having vertigo despite medical therapy. INTERVENTION IT dexamethasone injections as needed to control vertigo attacks. MAIN OUTCOME MEASURE A Kaplan… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Similar Papers

Loading similar papers…